StreetAlpha.app
Home › Stocks › MDWD

MediWound Ltd. (MDWD)

$13.68
▲ +0.96%
LAST CLOSE · NOV 17

MediWound develops enzyme-based therapies that remove damaged tissue from burns and chronic wounds. It last closed at $13.68 on Nov 17, up 0.96% on the day. MDWD last reported earnings on Wed, May 27, 2026.

AI Auto Pilots
Is MDWD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$17.0M
−16.1% vs a year ago
Net income
−$23.9M
−140.8% margin
Free cash flow
−$21.6M
−127.5% margin
Gross margin
19.2%
$3.3M gross profit
Balance sheet
Cash & equivalents
$4.8M
At Dec 31
Shareholder equity
$43.6M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $23.8M$23.8MFY2021FY2022: $26.5M$26.5MFY2022FY2023: $18.7M$18.7MFY2023FY2024: $20.2M$20.2MFY2024FY2025: $17.0M$17.0MFY2025

From MDWD's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 5). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Last report
May 27
2026 · Before the open (BMO)
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
±8.8%
Priced in before that report
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated MDWD in the past 90 days.
Average 12-month target
No price targets on MDWD in the past 90 days.
Latest rating changes
OppenheimerMaintained
Aug 14Buy$30
OppenheimerMaintained
May 28Buy$32
HC Wainwright & Co.Reiterated
May 28Buy$36
DateFirmActionRatingPrice target
Aug 14OppenheimerMaintainedBuy$30
May 28OppenheimerMaintainedBuy$32
May 28HC Wainwright & Co.ReiteratedBuy$36
Loading…

Technical Analysis

MDWD · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 3% above its 20 day and 3% above its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 54). The nearest support is the Pivot at $13.62, and the nearest resistance the swing high (Oct 29) at $13.99.

Short trendBullish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 5.0%/day
Key levels
$19.7052 week high+44.0%
$15.00200 day average+9.6%
$14.01Pivot R1+2.4%
$13.99Swing high (Oct 29)+2.3%
$13.68Last close
$13.62Pivot−0.4%
$13.59100 day average−0.7%
$13.54Swing low (Jun 2)−1.0%
$13.30Pivot S1−2.8%
$13.2720 day average−3.0%
$13.2150 day average−3.4%
$11.8052 week low−13.7%
Indicators
RSI (14)53.79Middle of its rangeNeutral
MACD0.16Below its signal lineBearish
Stochastic45.5Middle of its rangeNeutral
ADX (14)19.7No clear trend
Williams %R-44.5Oversold below −80, overbought above −20Neutral
CCI (20)45.1Oversold below −100, overbought above 100Neutral
Rate of change+2.2%Change over 10 sessionsBullish
ATR (14)$0.68Typical daily range, 5.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for MDWD

What happened before

See how MDWD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow MDWD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How MDWD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in MDWD in the last 90 days.

Loading…

See today’s whale options flow across the market →

MDWD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲41 buying vs 29 selling
  • ▲Shares held by funds +1.7%
  • ▲Funds holding +7
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding8679+8.9%
In funds' top 1021+100.0%
Held by funds–––
New / increased14 / 2714 / 29−4.7%
Reduced / sold out22 / 718 / 10+3.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MDWD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MDWD is in one of them and how their past MDWD trades turned out.

MDWD in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MDWD in an article yet. Here's the latest on the wider market.

About MediWound

MediWound develops enzyme-based therapies that remove damaged tissue from wounds while leaving healthy tissue in place. Its main product, NexoBrid, treats deep burns and is approved in many countries. The company is also developing EscharEx, a topical treatment for chronic wounds such as venous leg ulcers, and a candidate for basal cell carcinoma. It makes its products at its facility in Yavne, Israel, and its customers are hospitals and healthcare providers treating burn and wound patients.

Headquarters
Yavne, Israel